Unknown

Dataset Information

Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial.


ABSTRACT:

Background

Anemia is highly prevalent in chronic kidney disease (CKD). Elevated hepcidin concentrations are an important mediator of disordered iron metabolism, a key mechanism underlying anemia of CKD. Vitamin D was recently shown to reduce serum hepcidin concentrations in healthy individuals. We examined whether treatment with calcitriol reduces serum hepcidin in individuals with CKD.

Methods

A total of 40 participants with stage 3 or 4 CKD (eGFR 15-60 ml/min/1.73m2) were randomized to receive either oral calcitriol 0.5 mcg daily or identically-matched placebo for 6 weeks. The primary outcome variable was change in serum hepcidin concentrations. Secondary outcomes variables included the change in iron parameters, calcium, phosphorus, intact parathyroid hormone a

SUBMITTER: Panwar B 

PROVIDER: S-EPMC5807766 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature